Estrogen Receptor Positive Breast Cancer Active Not Recruiting Phase 1 / 2 Trials for Capivasertib (DB12218)

Also known as: Oestrogen receptor positive breast cancer

IndicationStatusPhase
DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01992952Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast CancerTreatment